347 related articles for article (PubMed ID: 16901791)
1. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast.
Parsons AB; Lopez A; Givoni IE; Williams DE; Gray CA; Porter J; Chua G; Sopko R; Brost RL; Ho CH; Wang J; Ketela T; Brenner C; Brill JA; Fernandez GE; Lorenz TC; Payne GS; Ishihara S; Ohya Y; Andrews B; Hughes TR; Frey BJ; Graham TR; Andersen RJ; Boone C
Cell; 2006 Aug; 126(3):611-25. PubMed ID: 16901791
[TBL] [Abstract][Full Text] [Related]
2. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways.
Parsons AB; Brost RL; Ding H; Li Z; Zhang C; Sheikh B; Brown GW; Kane PM; Hughes TR; Boone C
Nat Biotechnol; 2004 Jan; 22(1):62-9. PubMed ID: 14661025
[TBL] [Abstract][Full Text] [Related]
3. Inference of protein complex activities from chemical-genetic profile and its applications: predicting drug-target pathways.
Han S; Kim D
PLoS Comput Biol; 2008 Aug; 4(8):e1000162. PubMed ID: 18769708
[TBL] [Abstract][Full Text] [Related]
4. Characterization of compound mechanisms and secondary activities by BioMAP analysis.
Berg EL; Kunkel EJ; Hytopoulos E; Plavec I
J Pharmacol Toxicol Methods; 2006; 53(1):67-74. PubMed ID: 16040258
[TBL] [Abstract][Full Text] [Related]
5. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
6. Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets.
Hughes T; Andrews B; Boone C
Cell; 2004 Jan; 116(1):5-7. PubMed ID: 14718160
[TBL] [Abstract][Full Text] [Related]
7. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
[TBL] [Abstract][Full Text] [Related]
8. Yeasts make their mark.
Chang F; Peter M
Nat Cell Biol; 2003 Apr; 5(4):294-9. PubMed ID: 12669083
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of roles for Puf1 and Puf2 proteins in the yeast response to high calcium.
Haramati O; Brodov A; Yelin I; Atir-Lande A; Samra N; Arava Y
Sci Rep; 2017 Jun; 7(1):3037. PubMed ID: 28596535
[TBL] [Abstract][Full Text] [Related]
12. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
[TBL] [Abstract][Full Text] [Related]
13. Functional annotation of chemical libraries across diverse biological processes.
Piotrowski JS; Li SC; Deshpande R; Simpkins SW; Nelson J; Yashiroda Y; Barber JM; Safizadeh H; Wilson E; Okada H; Gebre AA; Kubo K; Torres NP; LeBlanc MA; Andrusiak K; Okamoto R; Yoshimura M; DeRango-Adem E; van Leeuwen J; Shirahige K; Baryshnikova A; Brown GW; Hirano H; Costanzo M; Andrews B; Ohya Y; Osada H; Yoshida M; Myers CL; Boone C
Nat Chem Biol; 2017 Sep; 13(9):982-993. PubMed ID: 28759014
[TBL] [Abstract][Full Text] [Related]
14. A latent variable model for chemogenomic profiling.
Flaherty P; Giaever G; Kumm J; Jordan MI; Arkin AP
Bioinformatics; 2005 Aug; 21(15):3286-93. PubMed ID: 15919724
[TBL] [Abstract][Full Text] [Related]
15. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
Auer J; Bajorath J
J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
[TBL] [Abstract][Full Text] [Related]
16. Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity.
Farha MA; Brown ED
Chem Biol; 2010 Aug; 17(8):852-62. PubMed ID: 20797614
[TBL] [Abstract][Full Text] [Related]
17. Chemotography for multi-target SAR analysis in the context of biological pathways.
Lounkine E; Kutchukian P; Petrone P; Davies JW; Glick M
Bioorg Med Chem; 2012 Sep; 20(18):5416-27. PubMed ID: 22405595
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of a conditional hal3 vhs3 yeast mutant links potassium homeostasis with flocculation and invasiveness.
González A; Casado C; Petrezsélyová S; Ruiz A; Ariño J
Fungal Genet Biol; 2013 Apr; 53():1-9. PubMed ID: 23454581
[TBL] [Abstract][Full Text] [Related]
19. Studying phospholipid metabolism using yeast systematic and chemical genetics.
Fairn GD; McMaster CR
Methods; 2005 Jun; 36(2):102-8. PubMed ID: 15893935
[TBL] [Abstract][Full Text] [Related]
20. Yeast mutants as a model system for identification of determinants of chemosensitivity.
Perego P; Jimenez GS; Gatti L; Howell SB; Zunino F
Pharmacol Rev; 2000 Dec; 52(4):477-92. PubMed ID: 11121507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
